A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis
Abstract The interactions of fibroblast-like synoviocyte (FLS)-derived pro-inflammatory cytokines/chemokines and immune cells support the recruitment and activation of inflammatory cells in RA. Here, we show for the first time that the classical myokine myostatin (GDF-8) is involved in the recruitme...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0e68a05c59a446c9abd58a77cfaf8633 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0e68a05c59a446c9abd58a77cfaf8633 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0e68a05c59a446c9abd58a77cfaf86332021-12-02T16:15:06ZA myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis10.1038/s41598-021-93599-62045-2322https://doaj.org/article/0e68a05c59a446c9abd58a77cfaf86332021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93599-6https://doaj.org/toc/2045-2322Abstract The interactions of fibroblast-like synoviocyte (FLS)-derived pro-inflammatory cytokines/chemokines and immune cells support the recruitment and activation of inflammatory cells in RA. Here, we show for the first time that the classical myokine myostatin (GDF-8) is involved in the recruitment of Th17 cells to inflammatory sites thereby regulating joint inflammation in a mouse model of TNFalpha-mediated chronic arthritis. Mechanistically, myostatin-deficiency leads to decreased levels of the chemokine CCL20 which is associated with less infiltration of Th17 cells into the inflamed joints. In vitro, myostatin alone or in combination with IL-17A enhances the secretion of CCL20 by FLS whereas myostatin-deficiency reduces CCL20 secretion, associated with an altered transmigration of Th17 cells. Thus, the communication between activated FLS and Th17 cells through myostatin and IL-17A may likely contribute to a vicious cycle of inflammation, accounting for the persistence of joint inflammation in chronic arthritis. Blockade of the CCL20–CCR6 axis by inhibition of myostatin may, therefore, be a promising treatment option for chronic inflammatory diseases such as arthritis.Michelle FennenToni WeinhageVanessa KrackeJohanna IntemannGeorg VargaCorinna WehmeyerDirk FoellAdelheid Korb-PapThomas PapBerno DankbarNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Michelle Fennen Toni Weinhage Vanessa Kracke Johanna Intemann Georg Varga Corinna Wehmeyer Dirk Foell Adelheid Korb-Pap Thomas Pap Berno Dankbar A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis |
description |
Abstract The interactions of fibroblast-like synoviocyte (FLS)-derived pro-inflammatory cytokines/chemokines and immune cells support the recruitment and activation of inflammatory cells in RA. Here, we show for the first time that the classical myokine myostatin (GDF-8) is involved in the recruitment of Th17 cells to inflammatory sites thereby regulating joint inflammation in a mouse model of TNFalpha-mediated chronic arthritis. Mechanistically, myostatin-deficiency leads to decreased levels of the chemokine CCL20 which is associated with less infiltration of Th17 cells into the inflamed joints. In vitro, myostatin alone or in combination with IL-17A enhances the secretion of CCL20 by FLS whereas myostatin-deficiency reduces CCL20 secretion, associated with an altered transmigration of Th17 cells. Thus, the communication between activated FLS and Th17 cells through myostatin and IL-17A may likely contribute to a vicious cycle of inflammation, accounting for the persistence of joint inflammation in chronic arthritis. Blockade of the CCL20–CCR6 axis by inhibition of myostatin may, therefore, be a promising treatment option for chronic inflammatory diseases such as arthritis. |
format |
article |
author |
Michelle Fennen Toni Weinhage Vanessa Kracke Johanna Intemann Georg Varga Corinna Wehmeyer Dirk Foell Adelheid Korb-Pap Thomas Pap Berno Dankbar |
author_facet |
Michelle Fennen Toni Weinhage Vanessa Kracke Johanna Intemann Georg Varga Corinna Wehmeyer Dirk Foell Adelheid Korb-Pap Thomas Pap Berno Dankbar |
author_sort |
Michelle Fennen |
title |
A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis |
title_short |
A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis |
title_full |
A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis |
title_fullStr |
A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis |
title_full_unstemmed |
A myostatin-CCL20–CCR6 axis regulates Th17 cell recruitment to inflamed joints in experimental arthritis |
title_sort |
myostatin-ccl20–ccr6 axis regulates th17 cell recruitment to inflamed joints in experimental arthritis |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/0e68a05c59a446c9abd58a77cfaf8633 |
work_keys_str_mv |
AT michellefennen amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT toniweinhage amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT vanessakracke amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT johannaintemann amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT georgvarga amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT corinnawehmeyer amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT dirkfoell amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT adelheidkorbpap amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT thomaspap amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT bernodankbar amyostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT michellefennen myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT toniweinhage myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT vanessakracke myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT johannaintemann myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT georgvarga myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT corinnawehmeyer myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT dirkfoell myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT adelheidkorbpap myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT thomaspap myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis AT bernodankbar myostatinccl20ccr6axisregulatesth17cellrecruitmenttoinflamedjointsinexperimentalarthritis |
_version_ |
1718384274967625728 |